Page last updated: 2024-08-24

triciribine and Anoxemia

triciribine has been researched along with Anoxemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdalla, M; Ergul, A; Fagan, SC; Prakash, R; Sabbineni, H; Somanath, PR1
Abeyrathna, P; Han, W; Kovacs, L; Su, Y1

Other Studies

2 other study(ies) available for triciribine and Anoxemia

ArticleYear
The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.
    British journal of pharmacology, 2015, Volume: 172, Issue:16

    Topics: Animals; Cells, Cultured; Fibroblasts; Humans; Hypoxia; Lung; Male; Mice, Knockout; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Ribonucleosides; Thrombospondin 1; Transforming Growth Factor beta

2015
Calpain-2 activates Akt via TGF-β1-mTORC2 pathway in pulmonary artery smooth muscle cells.
    American journal of physiology. Cell physiology, 2016, 07-01, Volume: 311, Issue:1

    Topics: Animals; Becaplermin; Benzamides; Calpain; Cell Proliferation; Cells, Cultured; Collagen; Cysteine Proteinase Inhibitors; Dioxoles; Dipeptides; Disease Models, Animal; Enzyme Activation; Humans; Hypertension, Pulmonary; Hypoxia; Mechanistic Target of Rapamycin Complex 2; Mice, Knockout; Multiprotein Complexes; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Receptors, Transforming Growth Factor beta; Ribonucleosides; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Transforming Growth Factor beta1; Vascular Remodeling

2016